Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Strategy & Execution

How-tos, frameworks, omnichannel planning, and marketing roadmaps.

Sales Playbooks for High-Barrier Hospital Accounts | Hospital Account Strategy
Posted in
  • Case Studies & Trends
  • Industry Landscape
  • Strategy & Execution

Sales Playbooks for High-Barrier Hospital Accounts | Hospital Account Strategy

U.S. hospitals control almost $1.4 trillion in annual spending according to the American Hospital Association.https://www.aha.org/statistics/fast-facts-us-hospitals Yet … Sales Playbooks for High-Barrier Hospital Accounts | Hospital Account StrategyRead more

by Jayshree Gondane•December 5, 2025December 5, 2025•0
10 Most Important Attributes of High-Performing Medical Affairs Teams in the Pharma Industry
Posted in
  • Digital Transformation
  • Industry Landscape
  • Strategy & Execution

10 Most Important Attributes of High-Performing Medical Affairs Teams in the Pharma Industry

The pharma industry keeps redefining what credibility looks like. Stakeholders demand clarity. Regulators demand rigor. Physicians … 10 Most Important Attributes of High-Performing Medical Affairs Teams in the Pharma IndustryRead more

by Gurinder Khera•December 5, 2025December 5, 2025•0
5 Strategies Every Pharma Sales Rep in the US Must Master to Excel in a Hyper-Competitive Market
Posted in
  • Industry Landscape
  • Regulatory Compliance
  • Strategy & Execution

5 Strategies Every Pharma Sales Rep in the US Must Master to Excel in a Hyper-Competitive Market

Walk through any major healthcare network in the US and pay attention to how physicians operate … 5 Strategies Every Pharma Sales Rep in the US Must Master to Excel in a Hyper-Competitive MarketRead more

by Gurinder Khera•December 5, 2025December 5, 2025•0
Building Territory Heatmaps Using Real-Time Prescribing Trends to Optimize Pharma Sales in the U.S.
Posted in
  • Strategy & Execution

Building Territory Heatmaps Using Real-Time Prescribing Trends to Optimize Pharma Sales in the U.S.

In 2025, the U.S. pharmaceutical market operates in one of the most competitive landscapes in history. … Building Territory Heatmaps Using Real-Time Prescribing Trends to Optimize Pharma Sales in the U.S.Read more

by Jayshree Gondane•December 4, 2025December 4, 2025•0
AI Training Modules That Boost Pharma Rep Productivity AI Pharma Training
Posted in
  • Strategy & Execution

AI Training Modules That Boost Pharma Rep Productivity AI Pharma Training

Pharmaceutical reps face increasingly complex demands: large product portfolios, rigorous regulatory standards, and highly informed healthcare … AI Training Modules That Boost Pharma Rep Productivity AI Pharma TrainingRead more

by Jayshree Gondane•December 3, 2025December 3, 2025•0
Precision HCP Targeting Using Micro-Segmentation Models HCP micro segmentation
Posted in
  • Strategy & Execution

Precision HCP Targeting Using Micro-Segmentation Models HCP micro segmentation

Pharmaceutical marketers increasingly face the challenge of reaching the right healthcare providers (HCPs) with highly targeted … Precision HCP Targeting Using Micro-Segmentation Models HCP micro segmentationRead more

by Jayshree Gondane•December 3, 2025December 3, 2025•0
HOW PHARMA REPS CAN USE PREDICTIVE ANALYSIS FOR HIGH- VALUE CALLS PREDICTIVE ANALYTICS PHARMA SALES.
Posted in
  • Industry Landscape
  • Strategy & Execution

HOW PHARMA REPS CAN USE PREDICTIVE ANALYSIS FOR HIGH- VALUE CALLS PREDICTIVE ANALYTICS PHARMA SALES.

Targeting Smarter, Not Harder In 2024, U.S. pharmaceutical sales representatives spend over 40% of their field … HOW PHARMA REPS CAN USE PREDICTIVE ANALYSIS FOR HIGH- VALUE CALLS PREDICTIVE ANALYTICS PHARMA SALES.Read more

by Jayshree Gondane•December 2, 2025December 3, 2025•0
Eli Lilly Trades AI Access for Biotech Data to Drive Precision Marketing in Obesity and Alzheimer’s
Posted in
  • Case Studies & Trends
  • Strategy & Execution

Eli Lilly Trades AI Access for Biotech Data to Drive Precision Marketing in Obesity and Alzheimer’s

When you think about how artificial intelligence is changing the pharmaceutical industry, drug discovery and clinical … Eli Lilly Trades AI Access for Biotech Data to Drive Precision Marketing in Obesity and Alzheimer’sRead more

by Gurinder Khera•November 4, 2025November 4, 2025•0
Optimizing ROI Measurement: Overcoming Market Access Challenges in Pharma Sales
Posted in
  • Industry Landscape
  • Strategy & Execution

Optimizing ROI Measurement: Overcoming Market Access Challenges in Pharma Sales

You look at the latest sales report and notice a familiar issue: your market access team … Optimizing ROI Measurement: Overcoming Market Access Challenges in Pharma SalesRead more

by Gurinder Khera•October 22, 2025October 22, 2025•0
Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma Marketing
Posted in
  • Industry Landscape
  • Strategy & Execution

Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma Marketing

The glossy world of pharmaceutical advertising is facing its biggest regulatory reset in two decades. For … Direct-to-Consumer Advertising Oversight: How FDA’s Crackdown Is Redefining Pharma MarketingRead more

by Gurinder Khera•October 4, 2025October 4, 2025•0

Posts pagination

Previous 1 … 12 13 14 … 21 Next

Recent Posts

  • Understanding Prior Authorization in Pharmaceutical Sales
  • Side Hustles for Pharmaceutical Sales Representatives
  • How to Handle Burnout in Pharmaceutical Sales
  • Work-Life Balance Tips for Pharmaceutical Sales Reps
  • Continuing Education Options for Pharma Professionals

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A